Akeso Presents P-II (COMPASSION-03) Trial Data on Cadonilimab for R/M Cervical Cancer at ESGO 2026
Shots: Ref: PRnewswire | Image: Akeso | Press Release Related News: Akeso Receives NMPA Approval to Initiate P-II Trials…
Read article →
Sino Biopharmaceutical and Sanofi Partner to Advance Rovadicitinib in a ~$1.53B Deal
Shots: Ref: Sino | Image: Sino & Sanofi | Press Release Related News: The US FDA Approves Regeneron and Sanofi’s…
Read article →
Top 20 Radiopharmaceutical Companies of 2026
Shots: 20. Radiopharm Theranostics Market Cap: 60.99M Founded Year: 2021 Total Employees: 20 Headquarters: Sydney,…
Read article →
GSK Reports the MHLW’s NDA Acceptance for Bepirovirsen to Treat Chronic Hepatitis B
Shots: Ref: GSK | Image: GSK | Press Release Related News: GSK Reports the NMPA’s NDA Acceptance with Priority Review of…
Read article →
Ionis’ Olezarsen sNDA Secures the US FDA Priority Review for Severe Hypertriglyceridemia
Shots: Ref: Ionis | Image: Ionis | Press Release Related News: The EC Approves Ionis and Otsuka’s Dawnzera…
Read article →
Galderma Announces OLYMPIA Extension Study Data on Nemluvio for Prurigo Nodularis
Shots: Ref: Businesswire | Image: Galderma | Press Release Related News: Galderma Initiates P-II Studies of…
Read article →
Bayer Reports P-III (PEACE-3) Trial Data on Xofigo Combination for Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases
Shots: Ref: Businesswire | Image: Bayer | Press Release Related News: Bayer Reports P-III (OCEANIC-STROKE) Trial Data on…
Read article →
The US FDA Grants Accelerated Approval to Boehringer Ingelheim’s Hernexeos for 1L HER2-Mutant NSCLC
Shots: Ref: BI | Image: BI | Press Release Related News: Boehringer Ingelheim Inks $500M+ Deal with Sitryx…
Read article →